FDA Expands Market Access, Authorizes New ENDS Products
On May 5, 2026, the U.S. Food and Drug Administration (FDA) authorized the marketing of four Glas electronic nicotine delivery systems (ENDS) through the premarket tobacco product application (PMTA) pathway. Each product is an e-liquid pod containing 50mg/ml (or 5%) of tobacco-derived nicotine. The authorized pods include Classic Menthol, Fresh Menthol, Gold and Sapphire. This action marks the FDA’s first authorization of non-tobacco and non-menthol ENDS products. Read more
here.